Results 71 to 80 of about 31,365 (278)

Malignant salivary gland tumours: Can fast neutron therapy results point the way to carbon ion therapy? [PDF]

open access: yes, 2013
BACKGROUND AND PURPOSE: To evaluate the outcome of malignant salivary gland tumours treated with neutron therapy to assess the potential for other high linear energy transfer (LET) beams.
Carrara, Henri   +6 more
core   +1 more source

Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma

open access: yesJournal of Otolaryngology - Head and Neck Surgery, 2018
Background Sinonasal adenoid cystic carcinoma is a rare malignancy of the head and neck. Cavernous sinus invasion from sinonasal adenoid cystic carcinoma and its related management have rarely been investigated.
Yi-Chan Lee   +7 more
doaj   +1 more source

Adenoid cystic carcinoma of the parotid metastasizing to liver: case report [PDF]

open access: yes, 2004
BACKGROUND: Adenoid cystic carcinoma is a rare malignant parotid tumor. Metastasis can occur even a decade or more after initial treatment of the primary.
K Harish, SR Mangala Gouri
core   +3 more sources

Regulation of R‐Loop Dynamics by Proteins and Long Noncoding RNAs: An Emerging Paradigm for Cancer Treatment

open access: yesCancer Science, EarlyView.
R‐loops are three‐stranded nucleic acid structures whose dysregulation leads to genomic instability and cancer progression. This review summarizes the protein and lncRNA machineries that regulate R‐loop dynamics and discusses the therapeutic potential of targeting these pathways in cancer.
Miho M. Suzuki   +3 more
wiley   +1 more source

Adenoid Cystic Carcinoma Nose Masquerading as Basal Cell Adenoma

open access: yesOnline Journal of Health & Allied Sciences, 2020
Basal cell adenoma is a benign basaloid cell tumor involving salivary glands. It requires biopsy and histopathology to distinguish from pleomorphic adenoma, adenoid cystic carcinoma and basal cell adenocarcinoma.
Anjali Singh   +4 more
doaj  

A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma [PDF]

open access: yes, 2014
BACKGROUND: The aim of this study was to examine the efficacy and safety of everolimus in patients with progressive unresectable adenoid cystic carcinoma (ACC).
Byoung Chul Cho   +11 more
core   +2 more sources

Adenoid Cystic Carcinoma of Trachea [PDF]

open access: yesIndian Journal of Surgery, 2016
Adenoid cystic carcinoma (ACC) is the second most common primary malignant tumor of the trachea, after squamous cell carcinoma. Patients present with upper airway obstructive symptoms and signs including dyspnoea, cough, haemoptysis, and stridor which are often insidious, delaying diagnosis and optimal management.
Ashish, Varghese   +2 more
openaire   +2 more sources

Challenging the Role of Subtotal Resection Following Proton Radiotherapy for Adenoid Cystic Carcinoma of the Head and Neck [PDF]

open access: bronze, 2023
Ewa Augustin   +10 more
openalex   +1 more source

The spectrum of breast in situ papillary carcinomas with invasion and invasive breast carcinomas with papillary features: an overview of histological subtypes and diagnostic challenges

open access: yesHistopathology, EarlyView.
Invasive breast carcinomas with papillary features (IBCP) comprise diverse subtypes with variable architecture, histopathology, and clinical behaviour. This review outlines evolving classification, diagnostic criteria, and treatment implications, highlighting challenges in distinguishing in situ from invasive lesions. Standardised diagnostic approaches
Emad A Rakha   +2 more
wiley   +1 more source

Review of salivary gland neoplasms [PDF]

open access: yes, 2012
Salivary gland tumours most often present as painless enlarging masses.Most are located in the parotid glands andmost are benign. The principal hurdle in their management lies in the difficulty in distinguishing benign from malignant tumours ...
Chan, JYW, To, VSH, Tsang, RKY, Wei, WI
core   +1 more source

Home - About - Disclaimer - Privacy